Close

Rigel Pharma (RIGL) Announced Second FIT Phase 3 of Fostamatinib Did Not Meet Primary Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. NVDA
4. HDB
5. PPG
6. HDFCB:IN
7. WIT
8. META
9. HDFCAMC:IN
10. CRM


Go back to Rigel Pharma (RIGL) Announced Second FIT Phase 3 of Fostamatinib Did Not Meet Primary Endpoint

Rigel Pharma (RIGL) trading halted with news pending

October 20, 2016 6:55 AM EDT

Rigel Pharma (NASDAQ: RIGL) trading halted with news pending.

... More